1. Kreek, M.J., LaForge, K.S. & Butelman, E. Pharmacotherapy of addictions.Nat. Rev. Drug Discov.1, 710–726 (2002).

   Article CAS  Google Scholar 

2. Kreek, M.J., Bart, G., Lilly, C., LaForge, K.S. & Nielsen, D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.Pharmacol. Rev.57, 1–26 (2005).

   Article CAS  Google Scholar 

3. Kosten, T.A. et al. Miserendino, M.J. & Haile, C.N., DeCaprio, J.L., Jatlow, P.I., Nestler, E.J. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains.Brain Res.778, 418–429 (1997).

   Article CAS  Google Scholar 

4. Tsuang, M.T. et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.Arch. Gen. Psychiatry55, 967–972 (1998).

   Article CAS  Google Scholar 

5. Kendler, K.S., Jacobson, K.C., Prescott, C.A. & Neale, M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.Am. J. Psychiatry160, 687–695 (2003).

   Article  Google Scholar 

6. Tsuang, M.T. et al. Genetic and environmental influences on transitions in drug use.Behav. Genet.29, 473–479 (1999).

   Article CAS  Google Scholar 

7. Foroud, T. et al. Alcoholism susceptibility loci: Confirmation studies in a replicate sample and further mapping.Alcohol. Clin. Exp. Res.24, 933–945 (2000).

   Article CAS  Google Scholar 

8. Edenberg, H.J. et al. Variations in GABRA2, encoding the α2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations in the beta frequency.Am. J. Hum. Genet.74, 705–714 (2004).

   Article CAS  Google Scholar 

9. Wang, J.C. et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome.Hum. Mol. Genet.13, 1903–1911 (2004).

   Article CAS  Google Scholar 

10. Ott, J. Issues in association analysis: error control in case-control association studies for disease gene discovery.Hum. Hered.58, 171–174 (2004).

    Article  Google Scholar 

11. Kreek, M.J., Nielsen, D.A. & LaForge, K.S. Genes associated with addiction: alcoholism, opiate and cocaine addiction.Neuromolecular Med.5, 85–108 (2004).

    Article CAS  Google Scholar 

12. Nielsen, D.A. et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism.Arch. Gen. Psychiatry55, 593–602 (1998).

    Article CAS  Google Scholar 

13. Coccaro, E.F. et al. Familial correlates of reduced central serotonergic system function in patients with personality disorders.Arch. Gen. Psychiatry51, 318–324 (1994).

    Article CAS  Google Scholar 

14. Nielsen, D.A. et al. Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism.Arch. Gen. Psychiatry51, 34–38 (1994).

    Article CAS  Google Scholar 

15. Limosin, F. et al. Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men.Eur. Psychiatry20, 304–306 (2005).

    Article CAS  Google Scholar 

16. Lusher, J.M., Chandler, C. & Ball, D. Dopamine D4 receptor gene (DRD4) is associated with novelty seeking (NS) and substance abuse: the saga continues.Mol. Psychiatry6, 497–499 (2001).

    Article CAS  Google Scholar 

17. Schinka, J.A., Letsch, E.A. & Crawford, F.C. DRD4 and novelty seeking: results of meta-analyses.Am. J. Med. Genet. B Neuropsychiatr. For. Genet.114, 643–648 (2002).

    Article CAS  Google Scholar 

18. Primus, R.J. et al. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [³H]NGD 94–1.J. Pharmacol. Exp. Ther.282, 1020–1027 (1997).

    CAS PubMed  Google Scholar 

19. Uhl, G., Blum, K., Noble, E. & Smith, S. Substance abuse vulnerability and D2 receptor genes.Trends Neurosci.16, 83–88 (1993).

    Article CAS  Google Scholar 

20. Gelernter, J., Goldman, D. & Risch, N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal.J. Am. Med. Assoc.269, 1673–1677 (1993).

    Article CAS  Google Scholar 

21. Neville, M.J., Johnstone, E.C. & Walton, R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1.Hum. Mutat.23, 540–545 (2004).

    Article CAS  Google Scholar 

22. Rounsaville, B.J., Weissman, M.M., Crits-Christoph, K., Wilber, C. & Kleber, H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.Arch. Gen. Psychiatry39, 151–156 (1982).

    Article CAS  Google Scholar 

23. Levin, F. & Kleber, H. Attention deficit hyperactivity disorder and substance abuse: relationships and implications for treatment.Harv. Rev. Psychiatry2, 246–258 (1995).

    Article CAS  Google Scholar 

24. Kreek, M.J. Medical safety, side effects and toxicity of methadone.Proceedings of the Fourth National Conference on Methadone Treatment, National Association for the Prevention of Addiction to Narcotics (NAPAN)-NIMH, 171–174 (1972).

    Google Scholar 

25. Kreek, M.J. Opiates, opioids and addiction.Mol. Psychiatry1, 232–254 (1996).

    CAS PubMed  Google Scholar 

26. Schluger, J.H., Borg, L., Ho, A. & Kreek, M.J. Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.Neuropsychopharmacology24, 568–575 (2001).

    Article CAS  Google Scholar 

27. O'Malley, S.S., Krishnan-Sarin, S., Farren, C., Sinha, R. & Kreek, M.J. Naltrexone decreases craving and alcohol self-administration in alcohol dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.Psychopharmacology (Berl.)160, 19–29 (2002).

    Article CAS  Google Scholar 

28. Zhou, Y. et al. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during 'binge'-pattern cocaine administration and chronic withdrawal.J. Pharmacol. Exp. Ther.279, 351–358 (1996).

    CAS PubMed  Google Scholar 

29. Sinha, R. et al. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.Psychopharmacology (Berl.)170, 62–72 (2003).

    Article CAS  Google Scholar 

30. Bond, C. et al. Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction.Proc. Natl. Acad. Sci. USA95, 9608–9613 (1998).

    Article CAS  Google Scholar 

31. LaForge, K.S., Yuferov, V. & Kreek, M.J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions.Eur. J. Pharmacol.410, 249–268 (2000).

    Article CAS  Google Scholar 

32. Bart, G. et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.Mol. Psychiatry9, 547–549 (2004).

    Article CAS  Google Scholar 

33. Bart, G. et al. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.Neuropsychopharmacology30, 417–422 (2005).

    Article CAS  Google Scholar 

34. Lachman, H.M. et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.Pharmacogenetics6, 243–250 (1996).

    Article CAS  Google Scholar 

35. Oswald, L.M., McCaul, M., Choi, L., Yang, X. & Wand, G.S. Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report.Biol. Psychiatry55, 102–105 (2004).

    Article CAS  Google Scholar 

36. Caspi, A. et al. Role of genotype in the cycle of violence in maltreated children.Science297, 851–854 (2002).

    Article CAS  Google Scholar 

37. Caspi, A., Sugden, K. & Moffitt, T.E. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.Science301, 386–389 (2003).

    Article CAS  Google Scholar 

38. Hu, X. et al. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.Alcohol. Clin. Exp. Res.29, 8–16 (2005).

    Article CAS  Google Scholar 

39. Gelernter, J. et al. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia.Am. J. Med. Genet. B Neuropsychiatr. For. Genet.136, 45–52 (2005).

    Article  Google Scholar 

40. Uhl, G.R., Liu, Q.R. & Naiman, D. Substance abuse vulnerability loci: converging genome scanning data.Trends Genet.18, 420–425 (2002).

    Article CAS  Google Scholar 

41. Uhl, G. Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results.Ann. NY Acad. Sci.1025, 1–13 (2004).

    Article CAS  Google Scholar 

42. Yuferov, V. et al. Redefinition of the human kappa opioid receptor(OPRK1) structure and association of haplotypes with opiate addiction.Pharmacogenetics14, 793–804 (2004).

    Article CAS  Google Scholar 

43. Vandenbergh, D.J., Rodriguez, L.A., Miller, I.T., Uhl, G.R. & Lachman, H.M. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers.Am. J. Med. Genet.74, 439–442 (1997).

    Article CAS  Google Scholar 

44. Horowitz, R. et al. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study.Am. J. Med. Genet.96, 599–603 (2000).

    Article CAS  Google Scholar 

45. Li, T. et al. Association analysis of theDRD4 andCOMT genes in methamphetamine abuse.Am. J. Med. Genet. B Neuropsychiatr. For. Genet.129, 120–124 (2004).

    Article  Google Scholar 

46. Cubells, J.F. et al. A haplotype at DBH, associated with low plasma dopamine-β-hydroxylase activity, also associates with cocaine-induced paranoia.Mol. Psychiatry5, 56–63 (2000).

    Article CAS  Google Scholar 

47. Comings, D.E. et al. Cannabinoid receptor gene (CNR1): Association with IV drug use.Mol. Psychiatry2, 161–168 (1997).

    Article CAS  Google Scholar 

48. Schmidt, L.G. et al. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence.Drug Alcohol Depend.65, 221–224 (2002).

    Article CAS  Google Scholar 

49. Zhang, P-W. et al. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.Mol. Psychiatry9, 916–931 (2004).

    Article CAS  Google Scholar 

50. Sipe, J.C., Chiang, K., Gerber, A.L., Beutler, E. & Cravatt, B.F. A missense mutation in human fatty acid amide hydrolase associated with problem drug use.Proc. Natl. Acad. Sci. USA99, 8394–8399 (2002).

    Article CAS  Google Scholar 

Download references